Literature DB >> 25488994

Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome.

Kazuki Miyaji1, Jérôme Devaux2, Nobuhiro Yuki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25488994     DOI： 10.1212/WNL.0000000000001090

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

Review 1.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

2.  Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.

Authors:  Michiaki Koga; Masaki Takahashi; Keiko Yokoyama; Takashi Kanda
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

Review 3.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

4.  A coin-like peripheral small cell lung carcinoma associated with acute paraneoplastic axonal Guillain-Barre-like syndrome.

Authors:  Ioan Jung; Simona Gurzu; Rodica Balasa; Anca Motataianu; Anca Otilia Contac; Ioana Halmaciu; Septimiu Popescu; Iunius Simu
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

Review 5.  Perivascular Mesenchymal Stem/Stromal Cells, an Immune Privileged Niche for Viruses?

Authors:  Grégorie Lebeau; Franck Ah-Pine; Matthieu Daniel; Yosra Bedoui; Damien Vagner; Etienne Frumence; Philippe Gasque
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.